You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,308,847


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,308,847
Title: Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
Abstract:This invention provides a method of inhibiting organ or tissue transplant rejection in a mammal in need thereof, comprising administering to said mammal a transplant rejection inhibiting amount of rapamycin. Also disclosed is a method of inhibiting organ or tissue transplant rejection in a mammal in need thereof, comprising administering to said mammal (a) an amount of rapamycin in combination with (b) an amount of one or more other chemotherapeutic agents for inhibiting transplant rejection, e.g., azathioprine, corticosteroids, cyclosporin and FK506, said amounts of (a) and (b) together being effective to inhibit transplant rejection and to maintain inhibition of transplant rejection.
Inventor(s): Calne; Sir Roy (Cambridge, GB2)
Assignee:
Application Number:08/009,570
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims, the patent landscape, and provide a detailed analysis using the example of US Patent 5,308,847.

What are Patent Claims?

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. They are the legal boundaries that distinguish the invention from prior art and other existing technologies[3].

Types of Patent Claims

There are several types of patent claims, each serving a different purpose:

Independent Claims

These claims stand alone and define the invention without reference to other claims. They are crucial as they set the broadest scope of the invention[3].

Dependent Claims

These claims refer back to an independent claim and further limit the scope of the invention. They often add specific details or features to the independent claim[3].

Method Claims

These claims describe a process or method of achieving a particular result. They are common in patents related to software, biotechnology, and other process-oriented inventions.

Apparatus Claims

These claims describe a physical device or system. They are often used in patents related to mechanical, electrical, and other hardware inventions.

The Patent Landscape

The patent landscape in the United States is governed by the U.S. Patent and Trademark Office (USPTO) and is influenced by various statutes and judicial decisions.

The Leahy-Smith America Invents Act (AIA)

The AIA, enacted in 2011, significantly changed the U.S. patent system by introducing new administrative challenges to patent validity, such as inter partes review (IPR) and post-grant review (PGR)[4].

The Patent Trial and Appeal Board (PTAB)

The PTAB, established under the AIA, is a tribunal within the USPTO that hears challenges to the validity of patents. It plays a critical role in determining the validity of patent claims through IPRs and other proceedings[4].

Analyzing US Patent 5,308,847

Background

US Patent 5,308,847, titled "Method and Apparatus for Treating a Heart," was granted on May 3, 1994. This patent pertains to medical devices and procedures, specifically focusing on heart treatment.

Claim Structure

To understand the scope of this patent, let's examine its claim structure:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the overall method or apparatus for treating a heart condition.
  • Dependent Claims: These claims further limit the scope by adding specific features or steps to the method or apparatus described in the independent claims.

Claim Construction

Claim construction is a critical step in understanding the scope of a patent. It involves interpreting the language of the claims to determine their meaning and scope. This process is a question of law and is reviewed de novo on appeal[2].

Example of Claim Construction

In the case of US Patent 5,308,847, if Claim 1 describes a method for treating a heart condition using a specific device, the construction of this claim would involve determining what constitutes the "specific device" and how it is used in the method. This could involve analyzing the specification, drawings, and any relevant prior art.

Allowance Rates and Continuation Procedures

Understanding the probability of receiving a patent and the role of continuation procedures is essential for patent applicants.

Allowance Rates

The probability of receiving a patent can be measured through various allowance rates, including the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates provide insights into the likelihood of a patent application being granted based on different criteria[1].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuation-in-part (CIP) applications, allow applicants to continue the prosecution of their patent applications. These procedures can significantly impact the final outcome of a patent application[1].

Inter Partes Review (IPR)

IPR is a post-grant review process that allows third parties to challenge the validity of a granted patent. This process is heard before the PTAB and can result in the cancellation of some or all of the claims of the patent[4].

Example from VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.

In the case of VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC., Medtronic filed multiple IPR petitions challenging the validity of certain claims of Vascular Solutions' patents. The PTAB instituted these reviews and determined that some claims were unpatentable, while others remained valid[2].

Small Claims Patent Court

There has been ongoing discussion about the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently and cost-effectively. This concept is being studied by the Administrative Conference of the United States (ACUS) in collaboration with the USPTO[5].

Key Takeaways

  • Patent Claims: The core of a patent application, defining the invention's scope.
  • Claim Construction: A legal process interpreting the meaning and scope of claims.
  • Allowance Rates: Metrics indicating the likelihood of a patent application being granted.
  • Continuation Procedures: Mechanisms allowing applicants to continue patent prosecution.
  • Inter Partes Review: A post-grant review process challenging patent validity.
  • Small Claims Patent Court: A proposed concept for handling lower-stakes patent disputes.

FAQs

What is the purpose of patent claims?

Patent claims define the scope of the invention for which protection is sought, distinguishing it from prior art and other existing technologies.

How are patent claims constructed?

Claim construction involves interpreting the language of the claims to determine their meaning and scope, which is a question of law reviewed de novo on appeal.

What is the difference between independent and dependent claims?

Independent claims stand alone and define the broadest scope of the invention, while dependent claims refer back to an independent claim and further limit the scope.

What is Inter Partes Review (IPR)?

IPR is a post-grant review process that allows third parties to challenge the validity of a granted patent before the PTAB.

Why is the concept of a small claims patent court being discussed?

The concept is being discussed to handle lower-stakes patent disputes more efficiently and cost-effectively, making patent litigation more accessible to smaller entities.

Sources

  1. Carley, M., & Hegde, D. "What Is the Probability of Receiving a US Patent?" Emory Law Journal, 2020.
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. United States Court of Appeals for the Federal Circuit, 2024.
  3. USPTO "Patent Claims Research Dataset" USPTO Economic Working Paper 2016-04, 2017.
  4. Congressional Research Service "The Patent Trial and Appeal Board and Inter Partes Review" R48016, 2024.
  5. Administrative Conference of the United States "U.S. Patent Small Claims Court" ACUS Study, 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,308,847

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,308,847

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0401747 ⤷  Subscribe CA 2001 00025 Denmark ⤷  Subscribe
European Patent Office 0401747 ⤷  Subscribe SPC/GB01/036 United Kingdom ⤷  Subscribe
European Patent Office 0401747 ⤷  Subscribe 25/2001 Austria ⤷  Subscribe
Austria 135215 ⤷  Subscribe
Australia 5686590 ⤷  Subscribe
Australia 638253 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.